Published in Blood Weekly, July 31st, 2003
Study results showed no increase in overall survival but a possible reduction in the rate of relapse, particularly among certain subgroups of patients.
The Susan G. Komen Breast Cancer Foundation asserts that while the studies offer new evidence in the pursuit of treatment options for high-risk breast cancer patients, it will still take time for these data to mature and for the results of other, ongoing studies to be...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.